(Q40093821)

17 September 2017

title

Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization (English)

1 reference

17 September 2017

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27497935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Younis Baqi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27497935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Samantha E Yohn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27497935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yumna Arif

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27497935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Allison Haley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27497935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Guiseppe Tripodi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27497935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Noemi San Miguel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27497935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Mercè Correa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27497935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

John D Salamone

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27497935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

6 August 2016

1 reference

17 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27497935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27497935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

19-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27497935%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

3575-3586

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27497935%20AND%20SRC:MED&resulttype=core&format=json

Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans

12 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Motor and cognitive aspects of motor retardation in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Cytokine, sickness behavior, and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Translational approaches to treatment-induced symptoms in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

A meta-analysis of cytokines in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

The role of dopamine in the pathophysiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Lack of ventral striatal response to positive stimuli in depressed versus normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

A phase II study of methylphenidate for the treatment of fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Multigram-scale syntheses, stability, and photoreactions of A2A adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Sickness behavior as a new target for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Role of muscles accumbens dopamine D1 and D2 receptors in instrumental and Pavlovian paradigms of conditioned reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Behavioral effects of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Effects of interleukin-1beta on food-maintained behavior in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Behavioral effects of the novel cannabinoid full agonist AM 411.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

The mysterious motivational functions of mesolimbic dopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Different behavioral effects of haloperidol, clozapine and thioridazine in a concurrent lever pressing and feeding procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Nucleus accumbens dopamine depletions make animals highly sensitive to high fixed ratio requirements but do not impair primary food reinforcement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: contrast between the effects of SKF 83566, raclopride, and fenfluramine on a concurrent choice task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Neurobiological basis of motivational deficits in psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

The pharmacology of effort-related choice behavior: Dopamine, depression, and individual differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Mesolimbic Dopamine and the Regulation of Motivated Behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

The novel adenosine A(2A) antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Slow phasic changes in nucleus accumbens dopamine release during fixed ratio acquisition: a microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Changes in nucleus accumbens and neostriatal c-Fos and DARPP-32 immunoreactivity during different stages of food-reinforced instrumental training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

The basal ganglia: a substrate for fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Reconsidering anhedonia in depression: lessons from translational neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

IL-6 mediated alterations on immobile behavior of rats in the forced swim test via ERK1/2 activation in specific brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-016-4392-9

Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself

21 January 2018

1 reference

12 December 2020

Dopamine and depression

1 reference

12 December 2020

Depression, anhedonia, and psychomotor symptoms: the role of dopaminergic neurocircuitry

1 reference

12 December 2020

Effect of single intracerebroventricular injection of alpha-interferon on monoamine concentrations in the rat brain

1 reference

12 December 2020

[Study on anxiety and depressive disorder of inpatients in general hospital]

1 reference

12 December 2020

Psychostimulants in the therapy of treatment-resistant depression Review of the literature and findings from a retrospective study in 65 depressed patients

1 reference

12 December 2020

Major depression during interferon-alpha treatment: vulnerability and prevention

1 reference

12 December 2020

Cytokine-induced sickness behavior: mechanisms and implications

1 reference

12 December 2020

Neo-striatal rCBF correlates of psychomotor slowing in patients with major depression

1 reference

12 December 2020